| Full text | |
| Author(s): Show less - |
Fernandez Alvarez, Karla Lucia
;
Beldi, Mariana
;
Sarmanho, Fabiane
;
Marques Rossetti, Renata Ariza
;
Farina Silveira, Caio Raony
;
Mota, Giana Rabello
;
Andreoli, Maria Antonieta
;
de Carvalho Caruso, Eliana Dias
;
Kamillos, Marcia Ferreira
;
Souza, Ana Marta
;
Mastrocalla, Haydee
;
Clavijo-Salomon, Maria Alejandra
;
Marzagao Barbuto, Jose Alexandre
;
Lorenzi, Noely Paula
;
Longatto-Filho, Adhemar
;
Baracat, Edmund
;
Mendoza Lopez, Rossana Veronica
;
Villa, Luisa Lina
;
Tacla, Maricy
;
Lepique, Ana Paula
Total Authors: 20
|
| Document type: | Journal article |
| Source: | SCIENTIFIC REPORTS; v. 7, AUG 21 2017. |
| Web of Science Citations: | 12 |
| Abstract | |
Cervical cancer is the last stage of a series of molecular and cellular alterations initiated with Human Papillomavirus (HPV) infection. The process involves immune responses and evasion mechanisms, which culminates with tolerance toward tumor antigens. Our objective was to understand local and systemic changes in the interactions between HPV associated cervical lesions and the immune system as lesions progress to cancer. Locally, we observed higher cervical leukocyte infiltrate, reflected by the increase in the frequency of T lymphocytes, neutrophils and M2 macrophages, in cancer patients. We observed a strong negative correlation between the frequency of neutrophils and T cells in precursor and cancer samples, but not cervicitis. In 3D tumor cell cultures, neutrophils inhibited T cell activity, displayed longer viability and longer CD16 expression half-life than neat neutrophil cultures. Systemically, we observed higher plasma G-CSF concentration, higher frequency of immature low density neutrophils, and tolerogenic monocyte derived dendritic cells, MoDCs, also in cancer patients. Interestingly, there was a negative correlation between T cell activation by MoDCs and G-CSF concentration in the plasma. Our results indicate that neutrophils and G-CSF may be part of the immune escape mechanisms triggered by cervical cancer cells, locally and systemically, respectively. (AU) | |
| FAPESP's process: | 08/57889-1 - Institute of Science and Technology to study Diseases Associated with Papillomavirus |
| Grantee: | Luisa Lina Villa |
| Support Opportunities: | Research Projects - Thematic Grants |
| FAPESP's process: | 14/19326-6 - Tumor microenvironment, inflammation and immunomodulation: therapeutic possibilities and prognostic markers |
| Grantee: | Ana Paula Lepique |
| Support Opportunities: | Regular Research Grants |